---
title: "Social Vulnerability and Risk of Mortality, Liver Disease, and Organ Complications in US Adults Wi"
id: "medrxiv-19-multidimensional-social-vulnerability-and-hepatic-and-extrahepatic-outcomes-in"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-19-multidimensional-social-vulnerability-and-hepatic-and-extrahepatic-outcomes-in"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.31.26361853v1?rss=1"
published_at: "2026-09-02T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Social Vulnerability and Risk of Mortality, Liver Disease, and Organ Complications in US Adults Wi
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-19-multidimensional-social-vulnerability-and-hepatic-and-extrahepatic-outcomes-in
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.31.26361853v1?rss=1)
- **Published At:** 2026-09-02T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This retrospective cohort study used TriNetX data from 110 US healthcare organizations (2010–2026) to assess the association of multidimensional **social vulnerability** (SV) with clinical outcomes in adults with **HIV/HBV** coinfection. - SV was defined across four domains: material, healthcare access and engagement, interpersonal, and psychosocial vulnerability. - The analytic sample comprised propensity score–matched groups of adults with HIV/HBV with and without documented SV, 2,024 individuals per group, totaling more than 15,900 person-years of follow-up. - SV was associated with a twofold increase in **mortality** (HR 2.06; 95% CI 1.72–2.47). - SV was linked to higher risk of composite liver events (HR 1.37; 95% CI 1.07–1.76), **hepatic decompensation** (HR 1.94; 95% CI 1.39–2.70), and hepatic failure (HR 2.39; 95% CI 1.53–3.73). - SV correlated with worse virologic control: **HBV viremia** (HR 1.69; 95% CI 1.32–2.16) and **HIV viremia** (HR 2.05; 95% CI 1.71–2.46). - SV was also associated with increased risk of **major adverse cardiovascular events** (HR 1.47), **chronic kidney disease** (HR 1.49), and **diabetes** (HR 1.25). - Multidomain SV showed generally stronger associations with hepatic and virologic outcomes than single-domain measures; healthcare access and engagement vulnerability had the most consistent associations with mortality and hepatic outcomes. - The authors conclude that SV assessment may improve risk stratification and identify intervention targets in HIV/HBV care. - The study used deidentified TriNetX data with IRB exemption; it is a preprint and has not been peer reviewed.
## Clinical Analysis & Structured Key Points
Multidimensional Social Vulnerability and Hepatic and Extrahepatic Outcomes in Adults With HIV/HBV Coinfection in the United States | medRxiv Skip to main content Multidimensional Social Vulnerability and Hepatic and Extrahepatic Outcomes in Adults With HIV/HBV Coinfection in the United States View ORCID Profile George Yendewa , Tayoot Chengsupanimit , Ali Dehghani , Ali Ahmed , Amir Mohareb , Chari Cohen , Michael Freeman , H. Nina Kim , Ighovwerka Ofotokun , Karine Dube doi: https://doi.org/10.64898/2026.08.31.26361853 George Yendewa 1 Case Western Reserve University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for George Yendewa For correspondence: gay7{at}case.edu Tayoot Chengsupanimit 1 Case Western Reserve University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ali Dehghani 1 Case Western Reserve University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ali Ahmed 2 University of Pennsylvania; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Amir Mohareb 3 Harvard Medical School; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Chari Cohen 4 Hepatitis B Foundation; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Michael Freeman 1 Case Western Reserve University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site H. Nina Kim 5 University of Washington Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ighovwerka Ofotokun 1 Case Western Reserve University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Karine Dube 2 University of Pennsylvania; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Info/History Metrics Data/Code Preview PDF Abstract Background: HIV/HBV coinfection is associated with substantial liver-related morbidity and mortality, yet the impact of social vulnerability (SV) on clinical outcomes has not been systematically assessed. We evaluated associations of multidimensional SV with mortality, hepatic, virologic, and extrahepatic organ outcomes among adults with HIV/HBV. Methods: We conducted a retrospective cohort study using TriNetX data from 110 U.S. healthcare organizations (2010-2026). We propensity score matched adults with HIV/HBV with and without documented SV 1:1 (2,024 per group). SV was defined using a four-domain framework encompassing material, healthcare access and engagement, interpersonal, and psychosocial vulnerability. Results: Over 15,900 person-years, SV was associated with higher mortality (hazard ratio [HR], 2.06; 95% confidence interval [CI], 1.72-2.47), liver composite events (HR, 1.37; 95% CI, 1.07-1.76), hepatic decompensation (HR, 1.94; 95% CI, 1.39-2.70), hepatic failure (HR, 2.39; 95% CI, 1.53-3.73), HBV viremia (HR, 1.69; 95% CI, 1.32-2.16), and HIV viremia (HR, 2.05; 95% CI, 1.71-2.46). SV was also associated with major adverse cardiovascular events (HR, 1.47), chronic kidney disease (HR, 1.49), and diabetes (HR, 1.25). Multidomain SV generally showed stronger associations than single-domain SV for most hepatic and virologic outcomes, with HR ranges of 1.76-2.62 versus 1.35-1.76 for single-domain SV. Healthcare access and engagement vulnerability was most consistently associated with mortality and hepatic outcomes. Conclusions: SV was associated with mortality, hepatic disease, impaired HIV/HBV control, extrahepatic organ morbidity, and acute care utilization in adults with HIV/HBV. SV assessment may improve risk stratification and identify actionable intervention targets during HIV/HBV care. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: TriNetX has obtained institutional review board exemption from the Western Institutional Review Board; because we used only deidentified data, additional institutional review board approval was not required for this study. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability All data produced in the present work are contained in the manuscript Funder Information Declared NIAID , 5UM1AI069501 , P30AI036219 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license . Back to top Previous Next Posted September 02, 2026. Download PDF Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Multidimensional Social Vulnerability and Hepatic and Extrahepatic Outcomes in Adults With HIV/HBV Coinfection in the United States Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Multidimensional Social Vulnerability and Hepatic and Extrahepatic Outcomes in Adults With HIV/HBV Coinfection in the United States George Yendewa , Tayoot Chengsupanimit , Ali Dehghani , Ali Ahmed , Amir Mohareb , Chari Cohen , Michael Freeman , H. Nina Kim , Ighovwerka Ofotokun , Karine Dube medRxiv 2026.08.31.26361853; doi: https://doi.org/10.64898/2026.08.31.26361853 Share This Article: Copy Citation Tools Multidimensional Social Vulnerability and Hepatic and Extrahepatic Outcomes in Adults With HIV/HBV Coinfection in the United States George Yendewa , Tayoot Chengsupanimit , Ali Dehghani , Ali Ahmed , Amir Mohareb , Chari Cohen , Michael Freeman , H. Nina Kim , Ighovwerka Ofotokun , Karine Dube medRxiv 2026.08.31.26361853; doi: https://doi.org/10.64898/2026.08.31.26361853 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area HIV/AIDS Subject Areas All Articles Addiction Medicine (614) Allergy and Immunology (896) Anesthesia (326) Cardiovascular Medicine (4769) Dentistry and Oral Medicine (474) Dermatology (407) Emergency Medicine (643) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1614) Epidemiology (15834) Forensic Medicine (32) Gastroenterology (1194) Genetic and Genomic Medicine (6983) Geriatric Medicine (727) Health Economics (1057) Health Informatics (4982) Health Policy (1426) Health Systems and Quality Improvement (1736) Hematology (581) HIV/AIDS (1335) Infectious Diseases (except HIV/AIDS) (16243) Intensive Care and Critical Care Medicine (1161) Medical Education (663) Medical Ethics (151) Nephrology (720) Neurology (7193) Nursing (363) Nutrition (1074) Obstetrics and Gynecology (1231) Occupational and Environmental Health (1001) Oncology (3573) Ophthalmology (1036) Orthopedics (393) Otolaryngology (446) Pain Medicine (466) Palliative Medicine (139) Pathology (704) Pediatrics (1772) Pharmacology and Therapeutics (733) Primary Care Research (759) Psychiatry and Clinical Psychology (5832) Public and Global Health (9690) Radiology and Imaging (2387) Rehabilitation Medicine and Physical Therapy (1432) Respiratory Medicine (1239) Rheumatology (633) Sexual and Reproductive Health (766) Sports Medicine (576) Surgery (766) Toxicology (107) Transplantation (302) Urology (286)
## Related Clinical Research

- [HBsAg clearance and occult HBV mutation in HIV/HBV-coinfected patients on ART](https://medichelpline.com/clinical-feed/medrxiv-7-hepatitis-b-surface-antigen-clearance-in-hiv-hbv-coinfected-patients-associated.md)
- [Social Determinants of Health Are More Common in HIV/HBV Coinfection Than in HIV or HBV Alone](https://medichelpline.com/clinical-feed/medrxiv-17-social-determinants-of-health-in-hiv-hbv-coinfection-compared-with-hiv-and-hbv.md)
- [Determinants of Favorable MDR-TB Treatment Outcomes in Zambia, 2018–2022](https://medichelpline.com/clinical-feed/plos-one-16-determinants-of-favorable-treatment-outcomes-in-multidrug-resistant.md)
- [Case report: ADMIO type 1 linked to de novo STAT3 gain-of-function mutation](https://medichelpline.com/clinical-feed/frontiers-in-immunology-16-a-case-report-of-admio-type-1-caused-by-a-de-novo-stat3-gain-of-function.md)
- [MMR vaccines: separating measles, mumps, rubella shots — myths and facts](https://medichelpline.com/clinical-feed/medical-news-today-0-should-the-measles-mumps-rubella-vaccines-be-separate-myths-vs-facts.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.